Suchergebnisse - "Kuter, David J"

PubPharm (241)

1

Correction to : Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study

enthalten in: Annals of hematology | 2024

von Röth, A. | Barcellini, W. | Anderson Tvedt, T. | +8

ErratumFor: Ann Hematol. 2022 Oct;101(10):2169-2177. - PMID 35999387

2

Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia

enthalten in: Blood advances | 2024

von Kuter, D. | Mayer, J. | Efraim, M. | +15

3

Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study

enthalten in: Annals of hematology | 2024

von Röth, A. | Barcellini, W. | Anderson Tvedt, T. | +8

4

The latest insights into rare blood disorders : Diagnosis and treatment strategies

enthalten in: American journal of hematology | 2024

von Kuter, D. | Cataland, S. | Broome, C. | +1

5

How I treat thrombocytopenia in pregnancy

enthalten in: Blood | 2024

von Fogerty, A. | Kuter, D.

CommentIn: Blood. 2024 Feb 29;143(9):739-740. - PMID 38421816

6

Avatrombopag for adults with early versus chronic immune thrombocytopenia

enthalten in: American journal of hematology | 2024

von Virk, Z. | Leaf, R. | Kuter, D. | +4

7

Avatrombopag for adults with early versus chronic immune thrombocytopenia

enthalten in: American Journal of Hematology | 2024

von Virk, Z. | Leaf, R. | Kuter, D. | +4

8

Fostamatinib for warm antibody autoimmune hemolytic anemia : Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD)

enthalten in: American journal of hematology | 2024

von Kuter, D. | Piatek, C. | Röth, A. | +4

9

Efficacy and safety of givosiran for acute hepatic porphyria : Final results of the randomized phase III ENVISION trial

enthalten in: Journal of hepatology | 2023

von Kuter, D. | Bonkovsky, H. | Monroy, S. | +10

10

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV) : a multicentre, randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Broome, C. | McDonald, V. | Miyakawa, Y. | +83

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]